tom's theory on the options., page-9

re: re:sbpo action Tom, take my word for it; human trials well under way. Part of animal trials, relevant to FDA approval for SBP002, will be released at the same time as human trials. Serve little other purpose at the moment. Remember, the human trials are ALL on patients with mesothelioma(asbestosis) as this is the pathway to get "orphan drug status" from FDA.
There is no reason why the human trials in the USA would produce anything different than the outstanding results obtained from the trials with SAP(special access patients) done in Australia already. SBP002 was effective on all the 5 types of mesothelioma cells.
Glad you have a position, same as me, as this is exciting stuff and general market weakness and lack of news is allowing me to keep adding to my holdings of both SBP/SBPO.
This a stock to hold for 12-24 months.